108 related articles for article (PubMed ID: 3986372)
1. [Cytotoxic action of natural killer cells on human tumor cells].
Avdeev GI; Viadro MM; Leĭkin IuD; Timofeevskaia EA; Osipov SG
Biull Eksp Biol Med; 1985 Apr; 99(4):471-3. PubMed ID: 3986372
[TBL] [Abstract][Full Text] [Related]
2. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
[TBL] [Abstract][Full Text] [Related]
3. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
4. Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.
Moy PM; Holmes EC; Golub SH
Cancer Res; 1985 Jan; 45(1):57-60. PubMed ID: 3855286
[TBL] [Abstract][Full Text] [Related]
5. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
6. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
Hagner G
Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
Uchida A; Yanagawa E
J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
[TBL] [Abstract][Full Text] [Related]
9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
10. Natural cytotoxicity in humans: susceptibility of freshly isolatd tumor cells to lysis.
Vose BM; Moore M
J Natl Cancer Inst; 1980 Aug; 65(2):257-63. PubMed ID: 6157044
[TBL] [Abstract][Full Text] [Related]
11. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
12. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
14. Decreased natural killer cell activity in children with untreated acute leukemia.
Nasrallah AG; Miale TD
Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019
[TBL] [Abstract][Full Text] [Related]
15. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
Klingemann HG; Wong E; Maki G
Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
[TBL] [Abstract][Full Text] [Related]
16. [Cytolytic activity of mononuclear cells, T-lymphocytes and monocytes of the peripheral blood in patients with lung cancer].
Speranskiĭ DL; Blokhina NG; Bykovskaia SN; Kupriianova TA
Biull Eksp Biol Med; 1988 Jul; 106(7):68-70. PubMed ID: 3261176
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of immunity and antitumor drugs against cancer. II. In vitro studies with cis-diamminedichloroplatinum in a human leukemia system.
De Filippi R; Fuggetta MP; Ricci F; Marini S; Caliendo R; Giuliani A
Chemioterapia; 1987 Dec; 6(6):410-6. PubMed ID: 2449291
[TBL] [Abstract][Full Text] [Related]
19. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
